111In-exendin uptake in the pancreas correlates with the β-cell mass and not with the α-cell mass

Diabetes

Volumn 64, Issue 4, 2015, Pages 1324-1328

  Brom, Maarten ^a   Joosten, Lieke ^a   Frielink, Cathelijne ^a   Boerman, Otto ^a   Gotthardt, Martin ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; EXENDIN I 111; GLUCAGON; INDIUM 111; TRACER; UNCLASSIFIED DRUG; EXENDIN 3; PEPTIDE; RADIOPHARMACEUTICAL AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA CELL MASS; CELL FRACTIONATION; CELL STRUCTURE; CELLULAR PARAMETERS; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; ISOTOPE LABELING; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RADIOACTIVITY; RAT; ANIMAL; DRUG EFFECTS; METABOLISM; PANCREAS;

ANIMALS; FEMALE; GLUCAGON-SECRETING CELLS; INSULIN-SECRETING CELLS; PANCREAS; PEPTIDES; RADIOPHARMACEUTICALS; RATS;

EID: 84929505658     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1212     Document Type: Article

References (17)

1. Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 2004;53(Suppl. 3): S16-S21
2. Gotthardt M, Eizirik DL, Cnop M, Brom M. Beta cell imaging -A key tool in optimized diabetes prevention and treatment. Trends Endocrinol Metab 2014;25: 375-377
3. 111In-labelled exendin. Diabetologia 2014;57: 950-959
4. Körner M, Stöckli M, Waser B, Reubi JC. GLP-1 receptor expression in human tumors and human normal tissues: Potential for in vivo targeting. J Nucl Med 2007;48: 736-743
5. Xu G, Kaneto H, Lopez-Avalos MD, Weir GC, Bonner-Weir S. GLP-1/exendin-4 facilitates beta-cell neogenesis in rat and human pancreatic ducts. Diabetes Res Clin Pract 2006;73: 107-110
6. Reubi JC, Perren A, Rehmann R, et al. Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass. Diabetologia 2010; 53: 2641-2645
7. Waser B, Reubi JC. Radiolabelled GLP-1 receptor antagonist binds to GLP-1 receptor-expressing human tissues. Eur J Nucl Med Mol Imaging 2014;41: 1166-1171
8. Pyke C, Heller RS, Kirk RK, et al. GLP-1 receptor localization in monkey and human tissue: Novel distribution revealed with extensively validated monoclonal antibody. Endocrinology 2014;155: 1280-1290
9. Heller RS, Kieffer TJ, Habener JF. Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas. Diabetes 1997;46: 785-791
10. Orskov C, Poulsen SS. Glucagonlike peptide-I-(7-36)-amide receptors only in islets of Langerhans. Autoradiographic survey of extracerebral tissues in rats. Diabetes 1991;40: 1292-1296
11. 2+ channel-dependent exocytosis. Cell Metab 2010;11: 543-553
12. Hörsch D, Göke R, Eissele R, Michel B, Göke B. Reciprocal cellular distribution of glucagon-like peptide-1 (GLP-1) immunoreactivity and GLP-1 receptor mRNA in pancreatic islets of rat. Pancreas 1997;14: 290-294
13. Moens K, Heimberg H, Flamez D, et al. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 1996;45: 257-261
14. Tornehave D, Kristensen P, Rømer J, Knudsen LB, Heller RS. Expression of the GLP-1 receptor in mouse, rat, and human pancreas. J Histochem Cytochem 2008;56: 841-851
15. Brom M, Oyen WJ, Joosten L, Gotthardt M, Boerman OC. 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET. Eur J Nucl Med Mol Imaging 2010;37: 1345-1355
16. Zeglis BM, Holland JP, Lebedev AY, Cantorias MV, Lewis JS. Radiopharmaceuticals for Imaging in Oncology with Special Emphasis on Positron-Emitting Agents. In Nuclear Oncology: Pathophysiology and Clinical Applications H. Strauss W, Ed. New York, Springer, 2012
17. Eriksson O, Espes D, Selvaraju RK, et al. Positron emission tomography ligand [11C]5-hydroxy-tryptophan can be used as a surrogate marker for the human endocrine pancreas. Diabetes 2014;63: 3428-3437